# | Title | Journal | Year | Citations |
---|
1 | PI3K/Akt signalling pathway and cancer | Cancer Treatment Reviews | 2004 | 1,918 |
2 | Metastatic bone disease: clinical features, pathophysiology and treatment strategies | Cancer Treatment Reviews | 2001 | 1,651 |
3 | Molecular mechanisms of resistance and toxicity associated with platinating agents | Cancer Treatment Reviews | 2007 | 1,338 |
4 | The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer | Cancer Treatment Reviews | 2013 | 1,051 |
5 | Osteosarcoma treatment – Where do we stand? A state of the art review | Cancer Treatment Reviews | 2014 | 1,028 |
6 | CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy | Cancer Treatment Reviews | 2018 | 867 |
7 | Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review | Cancer Treatment Reviews | 2008 | 832 |
8 | Elevated copper and oxidative stress in cancer cells as a target for cancer treatment | Cancer Treatment Reviews | 2009 | 801 |
9 | Epidemiology of childhood cancer | Cancer Treatment Reviews | 2010 | 769 |
10 | New therapeutic aspects of flavones: The anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin | Cancer Treatment Reviews | 2009 | 740 |
11 | Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors | Cancer Treatment Reviews | 2018 | 730 |
12 | Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials | Cancer Treatment Reviews | 1997 | 717 |
13 | Management of toxicities of immune checkpoint inhibitors | Cancer Treatment Reviews | 2016 | 706 |
14 | Interleukin-6 signaling pathway in targeted therapy for cancer | Cancer Treatment Reviews | 2012 | 585 |
15 | Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook | Cancer Treatment Reviews | 2020 | 573 |
16 | Primary bone osteosarcoma in the pediatric age: State of the art | Cancer Treatment Reviews | 2006 | 562 |
17 | The management of brain metastases | Cancer Treatment Reviews | 2003 | 560 |
18 | Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy | Cancer Treatment Reviews | 2003 | 554 |
19 | Leptomeningeal carcinomatosis | Cancer Treatment Reviews | 1999 | 491 |
20 | Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies | Cancer Treatment Reviews | 2003 | 484 |
21 | The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant | Cancer Treatment Reviews | 2015 | 482 |
22 | Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation | Cancer Treatment Reviews | 2003 | 481 |
23 | The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents | Cancer Treatment Reviews | 2011 | 480 |
24 | The proteasome: structure, function, and role in the cell | Cancer Treatment Reviews | 2003 | 472 |
25 | Molecular biology in breast cancer: Intrinsic subtypes and signaling pathways | Cancer Treatment Reviews | 2012 | 466 |
26 | Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization | Cancer Treatment Reviews | 2011 | 460 |
27 | Tolerability and safety of rituximab (MabThera®) | Cancer Treatment Reviews | 2005 | 442 |
28 | Clinical pharmacokinetics of tyrosine kinase inhibitors | Cancer Treatment Reviews | 2009 | 437 |
29 | Resistance to PD1/PDL1 checkpoint inhibition | Cancer Treatment Reviews | 2017 | 437 |
30 | The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: A systematic review of the literature | Cancer Treatment Reviews | 2016 | 432 |
31 | Mitomycin C: a review | Cancer Treatment Reviews | 1976 | 430 |
32 | Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensus | Cancer Treatment Reviews | 2015 | 430 |
33 | Local hyperthermia combined with radiotherapy and-/or chemotherapy: Recent advances and promises for the future | Cancer Treatment Reviews | 2015 | 414 |
34 | Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: Phenolic acids, monophenol, polyphenol, and their derivatives | Cancer Treatment Reviews | 2012 | 408 |
35 | Cisplatin (cis-diamminedichloroplatinum II) | Cancer Treatment Reviews | 1979 | 398 |
36 | Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs | Cancer Treatment Reviews | 2017 | 398 |
37 | Sarcoid reactions in malignant tumours | Cancer Treatment Reviews | 1986 | 394 |
38 | Molecular targeted therapy of glioblastoma | Cancer Treatment Reviews | 2019 | 386 |
39 | Multi-functional nanocarriers to overcome tumor drug resistance | Cancer Treatment Reviews | 2008 | 381 |
40 | Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy | Cancer Treatment Reviews | 1998 | 380 |
41 | Evolving role of uPA/uPAR system in human cancers | Cancer Treatment Reviews | 2008 | 371 |
42 | Epithelial cell adhesion molecule expression (CD326) in cancer: A short review | Cancer Treatment Reviews | 2012 | 363 |
43 | Predictive biomarkers in PD-1/PD-L1 checkpoint blockade immunotherapy | Cancer Treatment Reviews | 2015 | 358 |
44 | Cardiotoxicity of adriamycin and related anthracyclines | Cancer Treatment Reviews | 1976 | 356 |
45 | Targeting CDK4/6 in patients with cancer | Cancer Treatment Reviews | 2016 | 356 |
46 | Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy | Cancer Treatment Reviews | 2016 | 354 |
47 | The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets | Cancer Treatment Reviews | 2014 | 350 |
48 | Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review | Cancer Treatment Reviews | 2012 | 349 |
49 | Long-term outcome of laparoscopic surgery for colorectal cancer: A cochrane systematic review of randomised controlled trials | Cancer Treatment Reviews | 2008 | 346 |
50 | Survivin: A new target for anti-cancer therapy | Cancer Treatment Reviews | 2009 | 346 |